Alisol C is primarily studied for its potential biological activities, particularly in the field of pharmacology. It has shown promising anti-inflammatory effects, making it a candidate for research in treating chronic inflammatory diseases. Studies suggest it may help modulate immune responses by inhibiting pro-inflammatory cytokines and signaling pathways such as NF-κB. It is also being investigated for hepatoprotective properties, meaning it may help protect the liver from damage caused by toxins or disease. This makes it relevant in the development of treatments for liver conditions like hepatitis or fatty liver disease. Additionally, Alisol C exhibits potential anti-cancer activity. Research in vitro and in animal models indicates it may suppress the growth of certain tumor cells by inducing apoptosis and inhibiting cell proliferation, especially in liver and breast cancer lines. Due to its structural similarity to other bioactive triterpenoids, Alisol C is considered a lead compound in drug discovery, especially for metabolic and degenerative diseases. However, most of the current data come from preclinical studies, and further research is needed to evaluate its efficacy and safety in humans.